Dixian Luo

3.8k total citations · 1 hit paper
81 papers, 1.9k citations indexed

About

Dixian Luo is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Dixian Luo has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 25 papers in Cancer Research and 24 papers in Cell Biology. Recurrent topics in Dixian Luo's work include Aldose Reductase and Taurine (19 papers), CRISPR and Genetic Engineering (9 papers) and Cancer-related molecular mechanisms research (9 papers). Dixian Luo is often cited by papers focused on Aldose Reductase and Taurine (19 papers), CRISPR and Genetic Engineering (9 papers) and Cancer-related molecular mechanisms research (9 papers). Dixian Luo collaborates with scholars based in China, United States and Hong Kong. Dixian Luo's co-authors include Rongzhang He, Deliang Cao, Yin‐Yuan Mo, Duan‐Fang Liao, Duan‐Fang Liao, Jing Jiang, Zheng Hu, Weihao Luo, Chun Wang and Ruilan Yan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Dixian Luo

75 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples

2024 54 citations Shang Chen, Yaru Liu et al. Frontiers in Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dixian Luo China	25	1.2k	654	400	190	177	81	1.9k
Yingjie Xu China	26	1.7k 1.5×	395 0.6×	183 0.5×	312 1.6×	78 0.4×	92	2.8k
Ernesto Yagüe United Kingdom	30	1.6k 1.4×	632 1.0×	156 0.4×	830 4.4×	54 0.3×	60	2.5k
Malathy P.V. Shekhar United States	28	1.2k 1.1×	488 0.7×	198 0.5×	812 4.3×	127 0.7×	56	2.3k
Feifei Li China	27	1.4k 1.2×	453 0.7×	122 0.3×	241 1.3×	66 0.4×	120	2.2k
Chen Zhang China	21	1.3k 1.1×	709 1.1×	118 0.3×	366 1.9×	51 0.3×	89	2.2k
Chen‐Kung Chou Taiwan	27	996 0.9×	317 0.5×	146 0.4×	231 1.2×	112 0.6×	51	1.7k
Felicitas Genze Germany	25	1.4k 1.2×	445 0.7×	134 0.3×	420 2.2×	69 0.4×	40	2.2k
Béla Ózsvári United Kingdom	26	1.2k 1.1×	635 1.0×	108 0.3×	542 2.9×	125 0.7×	40	2.3k
Jie Gao China	24	910 0.8×	296 0.5×	108 0.3×	251 1.3×	87 0.5×	90	1.7k
Chundong Yu China	30	2.1k 1.8×	479 0.7×	189 0.5×	614 3.2×	38 0.2×	83	3.0k

Countries citing papers authored by Dixian Luo

Since Specialization

Citations

This map shows the geographic impact of Dixian Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dixian Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dixian Luo more than expected).

Fields of papers citing papers by Dixian Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dixian Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dixian Luo. The network helps show where Dixian Luo may publish in the future.

Co-authorship network of co-authors of Dixian Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Dixian Luo. A scholar is included among the top collaborators of Dixian Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dixian Luo. Dixian Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Yan, et al.. (2025). CRISPR/Cas13a-based Supersensitive Circulating Tumor DNA Assay for Detecting EGFR Mutations in Plasma. 13(1). 1 indexed citations

Wang, Shenglong, et al.. (2025). AKR1C3 promotes bile acid production and contributes to the occurrence and development of liver cancer by upregulating HMG-CoA reductase. ONCOLOGIE. 27(4). 615–629.

Lai, Kaitao, Shibing Long, Shah Faisal, et al.. (2025). Artificial Intelligence-Coupled Self-Calibrating SERS Spectroscopy for Robust Clinical Diagnosis of Diabetes and Associated Complications. Analytical Chemistry. 97(45). 25168–25180.

Jia, Yi, Jiao Du, Xue Chen, et al.. (2025). A circRNA–mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer. Proceedings of the National Academy of Sciences. 122(8). e2420383122–e2420383122. 4 indexed citations

Lu, Yingjun, Yonghao Ma, Quan Liu, & Dixian Luo. (2025). Recent progress in mass spectrometry-based liquid biopsy for cancer detection and analysis: A comprehensive review. TrAC Trends in Analytical Chemistry. 190. 118291–118291.

Chen, Shang, Yaru Liu, Shenglong Wang, et al.. (2024). Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples. Frontiers in Oncology. 14. 1432869–1432869. 54 indexed citations breakdown →

Zhao, Hui, Hui Gong, Peide Zhu, et al.. (2024). Deciphering the cellular and molecular landscapes of Wnt/β-catenin signaling in mouse embryonic kidney development. Computational and Structural Biotechnology Journal. 23. 3368–3378.

Li, Zhen, et al.. (2024). TRIM3 inhibits colorectal cancer cell migration and lipid droplet formation by promoting FABP4 degradation.. PubMed. 39(2). 239–250. 6 indexed citations

An, Jusung, Kongpeng Lv, Calvin V. Chau, et al.. (2024). Lutetium Texaphyrin–Celecoxib Conjugate as a Potential Immuno-Photodynamic Therapy Agent. Journal of the American Chemical Society. 146(28). 19434–19448. 32 indexed citations

10.

Yang, Yang, Zheng Hu, Jing Jiang, et al.. (2024). CRISPR/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in plasma. Communications Biology. 7(1). 657–657. 8 indexed citations

11.

Zou, Qingshuang, Guangchao Li, Xin Huang, et al.. (2024). Photo‐metallo‐immunotherapy: Fabricating Chromium‐Based Nanocomposites to Enhance CAR‐T Cell Infiltration and Cytotoxicity against Solid Tumors. Advanced Materials. 37(2). e2407425–e2407425. 14 indexed citations

12.

He, Yan, et al.. (2024). Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer. Journal of Nanobiotechnology. 22(1). 348–348. 16 indexed citations

13.

Zhu, Peide, Yangjia Liu, Yaoyao Tang, et al.. (2023). Bi-doped carbon quantum dots functionalized liposomes with fluorescence visualization imaging for tumor diagnosis and treatment. Chinese Chemical Letters. 35(4). 108689–108689. 36 indexed citations

14.

Wang, Li, Shaohui Zhang, Hao Wang, et al.. (2023). Rapid and ultrasensitive detection of mpox virus using CRISPR/Cas12b-empowered graphene field-effect transistors. Applied Physics Reviews. 10(3). 12 indexed citations

15.

Chen, Yingying, et al.. (2023). Liver proteomic analysis reveals the key proteins involved in host immune response to sepsis. PeerJ. 11. e15294–e15294. 3 indexed citations

16.

Liu, Quan, Zhe Sun, Yanhong Duo, et al.. (2023). Chromium Nanoparticles Improve Macrophage and T Cell Infiltration for Cancer Immunotherapy. ACS Materials Letters. 5(6). 1738–1751. 12 indexed citations

17.

Yang, Yuanyuan, Ziyi Mai, Yanxin Zhang, et al.. (2023). A Cascade Targeted and Mitochondrion-Dysfunctional Nanomedicine Capable of Overcoming Drug Resistance in Hepatocellular Carcinoma. ACS Nano. 17(2). 1275–1286. 30 indexed citations

18.

Chen, Juanjuan, Qiang Li, Fenxia Li, et al.. (2021). The spectrum of FVIII gene variants detected by next generation sequencing in 236 Chinese non-inversion hemophilia A pedigrees. Thrombosis Research. 202. 8–13. 8 indexed citations

19.

Li, Jia, Weihao Luo, Rongzhang He, et al.. (2021). AKR1B10 protects against UVC-induced DNA damage in breast cancer cells. Acta Biochimica et Biophysica Sinica. 53(6). 726–738. 3 indexed citations

20.

Wang, Chun, Ruilan Yan, Dixian Luo, et al.. (2009). Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls. Journal of Biological Chemistry. 284(39). 26742–26748. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact